CVS Health

CVS

Market cap $96.1B

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Earlier this year, CVS Health shares fell after reports that Medicare payment rates would only increase by 0.09% next year. However, with Medicare's final ruling selecting a much higher 2.5% escalation, CVS, like other healthcare stocks, have bounced back in price.

In the latest trading session, CVS Health (CVS) closed at $78.09, marking a -1.56% move from the previous day.

CVS Health stock has been volatile in recent years. Its financial performance has been improving, but analysts are likely still concerned about high costs.

These developments should help boost revenue and profitability for the giant company.

CVS Health and Bristol Myers Squibb are built to handle the toughest recessions. Both companies have maintained or increased their dividends through downturns over the past two decades.

Regulatory headwinds are weighing on CVS (CVS +0.06%) stock.

Optimism exists for the future of health care Survey highlights opportunities to deepen trust across the provider-payer relationship Friction points remain, with administrative burden cited as top challenge HARTFORD, Conn., April 8, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS) today announced research findings from the inaugural Aetna Provider Survey, a quarterly study that polls a representative sample of the U.S. provider market to better understand their perceptions, opportunities, and challenges today and into the future.

The stock market's weakness might not be over — but it's not too early to start building a list of stocks to consider buying when investors are willing to take on more risk.

The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation.